![]()
|
|
||||||||
J. Biol. Chem., Vol. 281, Issue 49, 37913-37920, December 8, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1


2
From the
Laboratory of Cell Growth and Differentiation, Institute of Molecular and Cellular Biosciences, University of Tokyo, Yayoi, Bunkyo-ku, Tokyo 113-0032, Japan and the
Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Corporation (JST), Kawaguchi, Saitama 332-0012, Japan
Adipocytes play a key role in energy homeostasis and several cytokines have been shown to regulate adipogenesis. While the interleukin (IL)-6 family of cytokines was previously reported to be involved in adipogenesis, roles of this family in adipogenesis and their mechanisms of action are not fully understood. Here we show that among the IL-6 family, oncostatin M (OSM) most strongly inhibits adipogenesis of 3T3-L1 cells and mouse embryonic fibroblasts (MEFs). We also demonstrate that OSM inhibits adipogenesis through the Ras/extracellular signal-regulated kinase (ERK) and signal transducer and activator of transcription (STAT) 5 signaling pathways. In addition, OSM inhibits the early phase of the differentiation without affecting cell proliferation throughout adipogenesis including mitotic clonal expansion. CCAAT/enhancer-binding protein (C/EBP)
, C/EBP
, and peroxisome proliferator-activated receptor (PPAR)
are known to be required for adipogenesis. Expression of C/EBP
and PPAR
was almost completely abrogated by OSM. In contrast, neither the mRNA nor protein level of C/EBP
was affected by OSM. Forced expression of C/EBP
induced differentiation in the presence of troglitazone, and OSM inhibited this C/EBP
-induced differentiation. Taken together, our results indicate that OSM inhibits the onset of terminal differentiation of adipocytes through the Ras/ERK and STAT5 signaling pathways by possibly regulating C/EBP
activity.
Received for publication, June 26, 2006 , and in revised form, October 5, 2006.
* This work was supported in part by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan and from the CREST program of JST. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 Recipient of a JSPS Research Fellowship for Young Scientists.
2 To whom correspondence should be addressed: Laboratory of Cell Growth and Differentiation, Institute of Molecular and Cellular Biosciences, The University of Tokyo, Yayoi, Bunkyo-ku, Tokyo 113-0032, Japan. Tel.: 81-3-5841-7884; Fax: 81-3-5841-8475; E-mail: miyajima{at}iam.u-tokyo.ac.jp.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
U. A. White, W. C. Stewart, R. L. Mynatt, and J. M. Stephens Neuropoietin Attenuates Adipogenesis and Induces Insulin Resistance in Adipocytes J. Biol. Chem., August 15, 2008; 283(33): 22505 - 22512. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Naiki, E. Saijou, Y. Miyaoka, K. Sekine, and A. Miyajima TRB2, a Mouse Tribbles Ortholog, Suppresses Adipocyte Differentiation by Inhibiting AKT and C/EBPbeta J. Biol. Chem., August 17, 2007; 282(33): 24075 - 24082. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |